NOVONIX Ltd Files 6-K, Appendix 3G Attached
Ticker: NVNXF · Form: 6-K · Filed: Oct 22, 2024 · CIK: 1859795
Sentiment: neutral
Topics: substantial-holding, filing, sec-form-6k
Related Tickers: NVX
TL;DR
NOVONIX 6-K filed: Big shareholder stake changed, check Appendix 3G.
AI Summary
NOVONIX Limited filed a Form 6-K on October 22, 2024, reporting changes in substantial holdings. Appendix 3G indicates a change in beneficial ownership for NOVONIX Ltd, with specific details of the change not fully elaborated in the provided text but filed as Exhibit 99.1.
Why It Matters
This filing signals a change in a significant shareholder's stake in NOVONIX, which could influence market perception and stock movement.
Risk Assessment
Risk Level: medium — Changes in substantial holdings can indicate shifts in investor confidence or strategic moves, requiring further analysis.
Key Players & Entities
- NOVONIX Limited (company) — Registrant
- Appendix 3G (document) — Filed as Exhibit 99.1
FAQ
What is the specific nature of the change in beneficial ownership reported in Appendix 3G?
The provided text states that Exhibit 99.1 is 'Appendix 3G (Notificat', implying it details a notification of change in substantial holding, but the specific details of the change are not included in this excerpt.
When was this Form 6-K filed with the SEC?
The Form 6-K was filed on October 22, 2024.
What is the Commission File Number for NOVONIX Limited?
The Commission File Number for NOVONIX Limited is 001-41208.
Does NOVONIX Limited file annual reports under Form 20-F or Form 40-F?
NOVONIX Limited indicates it files annual reports under cover of Form 20-F.
What is the principal executive office address of NOVONIX Limited?
The principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.
Filing Stats: 203 words · 1 min read · ~1 pages · Grade level 13.4 · Accepted 2024-10-22 09:11:59
Filing Documents
- nvx-6k-oct-24-10-21-app3.htm (6-K) — 18KB
- nvx-ex99_1.htm (EX-99.1) — 67KB
- img58969013_0.jpg (GRAPHIC) — 1KB
- 0000950170-24-116112.txt ( ) — 88KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: October 22, 2024